South Korea’s Ministry of Food and Drug Safety has criminally charged Beurre Biere maker, Brewguru, and its sellers, Virtual Company and GS Retail Co., for falsely labeling their beer.
The ministry also issued an advance notice to Brewguru to suspend the production of Beurre Biere beer for one month.
According to the ministry, Brewguru violated the Food Labeling and Advertising Act by using the French word “beurre” in the product name although the beer does not contain any butter.
The ministry argued that if a company wants to use "beurre" in its product name, which means butter in French, there should be butter in its manufacturing or processing system.
Brewguru insisted that the word “beurre” was just part of its product name without claiming and advertising that butter is in the list of ingredients.
The beer maker vowed to strive hard to vindicate their position even if the measures taken by the authorities are enforced,” an official at Brewguru said.
Since its launch in April last year, Beurre Biere has been selling briskly at major department stores’ pop-up stores, and alcohol specialty shops.


FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
Asian Currencies Hold Steady as Dollar Stays Firm Amid Middle East Uncertainty
Debate over H-1B visas shines spotlight on US tech worker shortages
Asian Markets Rally as Oil Prices Tumble and Middle East Peace Hopes Emerge
U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push 



